Makoto Ichiba

1.4k citations
11 papers · 1.2k indexed · 1 hit paper · h-index 8
Topics
Cytokine Signaling Pathways and Interactions (5 papers)Metastasis and carcinoma case studies (3 papers)Gastric Cancer Management and Outcomes (3 papers)
Partner nations
Japan

In The Last Decade

Makoto Ichiba

9 papers receiving 1.2k citations

Hit Papers

A central role for Stat3 in IL-6-induced regulation of gr...19962026200620161996100200300400500

Peers

Makoto Ichiba
Comparison fields: 5 of 79
  • Oncology 786
  • Molecular Biology 504
  • Immunology 420
  • Cancer Research 207
  • Pulmonary and Respiratory Medicine 178
Replace Byung Woog Kang with:
Byung Woog Kang South Korea
Richard Sharp United States
K Sumii Japan
Iris Tischoff Germany
Jean‐Christophe Sabourin France
Severino Montemurro Italy
Hisanori Kashizuka Japan
Sumiko Ohnami Japan
Karoline Sonneck Austria
Jiren Yu China
Makoto Ichiba relative to Byung Woog Kang South Korea Byung Woog Kang's profile →
Citations per field
00.5×3.2×
Byung Woog Kang · 1×
Citations per year

Countries citing papers authored by Makoto Ichiba

Since Specialization
Citations

This map shows the geographic impact of Makoto Ichiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Ichiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Ichiba more than expected).

Fields of papers citing papers by Makoto Ichiba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Ichiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Ichiba. The network helps show where Makoto Ichiba may publish in the future.

Co-authorship network of co-authors of Makoto Ichiba

This figure shows the co-authorship network connecting the top 25 collaborators of Makoto Ichiba. A scholar is included among the top collaborators of Makoto Ichiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makoto Ichiba. Makoto Ichiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 31
2
A CASE OF ASPIRIN-INDUCED COLONIC ULCER WITH SEVERE STENOSIS
0
3 17
4 100
5
[A bowel perforation with metallic stent placement for advanced rectal cancer during bevacizumab-based chemotherapy].
0
6 17
7 335
8 148
9 35
10
A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells.breakdown →
533
11 3

About Makoto Ichiba

Makoto Ichiba is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (5 papers), Metastasis and carcinoma case studies (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Oncology (786 citations), Immunology (420 citations) and Gastroenterology (90 citations). Makoto Ichiba has collaborated with scholars based in Japan. Frequent co-authors include Koichi Nakajima, Toshiyuki Fukada, Masahiko Hibi, Yojiro Yamanaka, Toshio Hirano, Kazuto Nakae, Hiroyuki Kojima, Takao Hirano, Masahiro Narimatsu and Katsunori Mizuno. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026